Who we are
Diversity and Inclusion
Penta Foundation Italy
Penta ID Innovation
News & Events
Penta Aperitivo Webinars
Work with us
Calls for service
The Immunological and Virological Consequences of Planned Treatment Interruptions in Children with HIV Infection.
A comparison of the pharmacokinetics of maraviroc during pregnancy and postpartum
HCV treatment in children and young adults with HIV/HCV co-infection in Europe
Missed opportunities for prevention of hepatitis B infection in childbearing women with HIV in Ukraine
Pharmacokinetics of paediatric lopinavir/ritonavir tablets in children when administered twice daily according to FDA weight bands.
Vaginal delivery as an option for HIV-infected women: decreasing late preterm delivery rates in a European cohort collaboration.
Missed opportunities among HIV-positive women to control viral replication during pregnancy and to have a vaginal delivery
Improvements in virological control among women conceiving on cART in Western Europe
Use of combination neonatal prophylaxis for the prevention of mother-to-child transmission of HIV infection in European high-risk infants.
The pharmacokinetics, safety and efficacy of tenofovir and emtricitabine in HIV-1-infected pregnant women
Outcomes after reinitiating antiretroviral therapy in children randomized to planned treatment interruptions in the PENTA 11 Study
Adherence to antiretroviral therapy and acceptability of planned treatment interruptions in HIV-infected children